Hs-CRP is associated with weight, BMI, and female sex but not with endothelial function in children with type 1 diabetes

Pediatric Diabetes

Volumn 10, Issue 1, 2009, Pages 44-51

  Mackenzie, Karen E ^a,b,e   Wiltshire, Esko J ^c   Peña, Alexia S ^a,b   Gent, Roger ^a   Hirte, Craig ^d   Piotto, Lino ^a   Couper, Jennifer J ^a,b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

CRP; T1DM; Vascular endothelium dependent relaxation

Indexed keywords

C REACTIVE PROTEIN; GLYCERYL TRINITRATE;

ADOLESCENT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MUSCLE DISEASE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOOTH MUSCLE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASODILATATION;

ADOLESCENT; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; DIABETES MELLITUS, TYPE 1; ENDOTHELIUM, VASCULAR; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN; MALE; MUSCLE, SMOOTH, VASCULAR; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFERENCE VALUES; SEX CHARACTERISTICS;

EID: 59149091150     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2008.00456.x     Document Type: Article

References (43)

1. Jarvisalo MJ, Harmoinen A, Hakanen M et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 2002: 22: 1323-1328.
2. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000: 102: 1000-1006.
3. Schram MT, Chaturvedi N, Schalkwijk C et al. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2003: 26: 2165-2173.
4. Romano M, Pomilio M, Vigneri S et al. Endothelial perturbation in children and adolescents with type 1 diabetes: Association with markers of the inflammatory reaction. Diabetes Care 2001: 24: 1674-1678.
5. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993: 362: 801-809.
6. Clarkson P, Celermajer DS, Donald AE et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 1996: 28: 573-579.
7. Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation 1993: 87: V67-V76.
8. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992: 340: 1111-1115.
9. Jarvisalo MJ, Raitakari M, Toikka JO et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 2004: 109: 1750-1755.
10. Singh TP, Groehn H, Kazmers A. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol 2003: 41: 661-665.
11. Wiltshire EJ, Gent R, Hirte C, Pena A, Thomas DW, Couper JJ. Endothelial dysfunction relates to folate status in children and adolescents with type 1 diabetes. Diabetes 2002: 51: 2282-2286.
12. Jarvisalo MJ, Lehtimaki T, Raitakari OT. Determinants of arterial nitrate-mediated dilatation in children: Role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness. Circulation 2004: 109: 2885-2889.
13. Aggoun Y, Bonnet D, Sidi D et al. Arterial mechanical changes in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2000: 20: 2070-2075.
14. Tounian P, Aggoun Y, Dubern B et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: A prospective study. Lancet 2001: 358: 1400-1404.
15. Woo KS, Chook P, Yu CW et al. Overweight in children is associated with arterial endothelial dysfunction and intima-media thickening. Int J Obes Relat Metab Disord 2004: 28: 852-857.
16. Aggoun Y, Tounian P, Dabbas-Tyan M et al. [Arterial rigidity and endothelial dysfunction in obese children]. Arch Mal Coeur Vaiss 2002: 95: 631-635.
17. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999: 340: 115-126.
18. Danesh J, Wheeler JG, Hirschfield GM et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004: 350: 1387-1397.
19. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002: 347: 1557-1565.
20. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997: 336: 973-979.
21. Koenig W, Sund M, Frohlich M et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999: 99: 237-242.
22. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000: 102: 2165-2168.
23. Mac Kenzie KE, Wiltshire EJ, Gent R, Hirte C, Piotto L, Couper JJ. Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus. Pediatrics 2006: 118: 242-253.
24. Pena AS, Wiltshire E, MacKenzie K et al. Vascular endothelial and smooth muscle function relates to body mass index and glucose in obese and nonobese children. J Clin Endocrinol Metab 2006: 91: 4467-4471.
25. Pena AS, Wiltshire E, Gent R, Hirte C, Couper J. Folic acid improves endothelial function in children and adolescents with type 1 diabetes. J Pediatr 2004: 144: 500-504.
26. Lambert M, Delvin EE, Paradis G, O'Loughlin J, Hanley JA, Levy E. C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clin Chem 2004: 50: 1762-1768.
27. Schalkwijk CG, Poland DC, van Dijk W et al. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: Evidence for chronic inflammation. Diabetologia 1999: 42: 351-357.
28. Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in type 1 diabetic patients without clinically manifest macroangiopathy. Diabet Med 2005: 22: 999-1004.
29. Pasceri V, Cheng JS, Willerson JT, Yeh ET. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001: 103: 2531-2534.
30. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: Implications for atherosclerosis. Circulation 2001: 103: 1194-1197.
31. Wu DM, Chu NF, Shen MH, Chang JB. Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children. J Clin Epidemiol 2003: 56: 94-100.
32. Suheyl Ezgu F, Hasanoglu A, Tumer L, Ozbay F, Aybay C, Gunduz M. Endothelial activation and inflammation in prepubertal obese Turkish children. Metabolism 2005: 54: 1384-1389.
33. Festa A, D'Agostino R Jr, Williams K et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001: 25: 1407-1415.
34. Kilpatrick ES, Keevil BG, Jagger C, Spooner RJ, Small M. Determinants of raised C-reactive protein concentration in type 1 diabetes. QJM 2000: 93: 231-236.
35. Krolewski AS, Kosinski EJ, Warram JH et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987: 59: 750-755.
36. Laing SP, Swerdlow AJ, Slater SD et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 2003: 46: 760-765.
37. Dorman JS, Laporte RE, Kuller LH et al. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes 1984: 33: 271-276.
38. Isasi CR, Deckelbaum RJ, Tracy RP, Starc TJ, Berglund L, Shea S. Physical fitness and C-reactive protein level in children and young adults: The Columbia University BioMarkers Study. Pediatrics 2003: 111: 332-338.
39. Coulon J, Willems D, Dorchy H. [Increase in C-reactive protein plasma levels during diabetes in infants and young adults]. Presse Med 2005: 34: 89-93.
40. Colhoun HM, Schalkwijk C, Rubens MB, Stehouwer CD. C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification. Diabetes Care 2002: 25: 1813-1817.
41. Picardi A, Valorani MG, Vespasiani Gentilucci U et al. Raised C-reactive protein levels in patients with recent onset type 1 diabetes. Diabetes Metab Res Rev 2007: 23: 211-214.
42. Gomes MB, Piccirillo LJ, Nogueira VG, Matos HJ. Acute-phase proteins among patients with type 1 diabetes. Diabetes Metab 2003: 29: 405-411.
43. Hayaishi-Okano R, Yamasaki Y, Katakami N et al. Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes Care 2002: 25: 1432-1438.